Aehr Test Systems (AEHR) Projected to Post Quarterly Earnings on Monday

Aehr Test Systems (NASDAQ:AEHR) is projected to post its Q1 2027 results after the market closes on Monday, November 2nd. Analysts expect the company to post earnings of $0.11 per share and revenue of $27.53 million for the quarter. Individuals are encouraged to explore the company’s upcoming Q1 2027 earnings overview page for the latest details on the call scheduled for Monday, November 2, 2026 at 5:00 PM ET.

Aehr Test Systems Price Performance

NASDAQ:AEHR opened at $55.34 on Monday. The company has a market capitalization of $1.81 billion, a P/E ratio of -230.57 and a beta of 3.47. The business has a fifty day simple moving average of $89.03 and a two-hundred day simple moving average of $90.86. Aehr Test Systems has a 1 year low of $18.70 and a 1 year high of $147.40.

Analyst Upgrades and Downgrades

A number of research analysts have recently commented on the company. Oppenheimer initiated coverage on Aehr Test Systems in a research report on Thursday, September 10th. They set an “outperform” rating and a $120.00 price target on the stock. Freedom Capital raised Aehr Test Systems from a “hold” rating to a “strong-buy” rating in a report on Thursday, July 16th. Craig Hallum restated a “buy” rating and issued a $125.00 price objective on shares of Aehr Test Systems in a research note on Wednesday, July 15th. Zacks Research cut Aehr Test Systems from a “strong-buy” rating to a “hold” rating in a research note on Monday, September 14th. Finally, Wall Street Zen raised shares of Aehr Test Systems from a “sell” rating to a “hold” rating in a report on Saturday, July 18th. One research analyst has rated the stock with a Strong Buy rating, five have issued a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, Aehr Test Systems presently has a consensus rating of “Moderate Buy” and an average target price of $132.50.

Insider Activity at Aehr Test Systems

In other Aehr Test Systems news, Director Laura Oliphant sold 1,717 shares of the firm’s stock in a transaction dated Wednesday, August 12th. The stock was sold at an average price of $133.00, for a total value of $228,361.00. Following the completion of the transaction, the director owned 16,100 shares in the company, valued at $2,141,300. This trade represents a 9.64% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Howard T. Slayen sold 5,700 shares of the firm’s stock in a transaction dated Friday, August 14th. The stock was sold at an average price of $133.03, for a total value of $758,271.00. Following the completion of the transaction, the director owned 140,667 shares of the company’s stock, valued at approximately $18,712,931.01. This represents a 3.89% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold a total of 109,475 shares of company stock worth $13,827,160 in the last 90 days. 4.60% of the stock is owned by company insiders.

Aehr Test Systems Company Profile

Aehr Test Systems (NASDAQ: AEHR) develops and manufactures test and burn-in equipment used to qualify and screen semiconductor devices. Its systems are designed to identify manufacturing defects and reliability issues before chips are shipped to customers, helping semiconductor manufacturers improve production yields and product quality.

The company’s product portfolio includes the FOX family of semiconductor test systems, including the FOX-XP, FOX-NP and FOX-1P platforms. Aehr also provides wafer contactors, DiePak carriers and related test fixtures and software.